background: Chemokine receptor CCR5, the main HIV-1 coreceptor, is present in the human spermatozoa. This study aimed to investigate (i) whether the percentage of CCR5-positive spermatozoa varies under conditions associated with changes in the membrane architecture, such as capacitation and fixation/permeabilization procedures; (ii) whether there is any relationship between individual variability in sperm CCR5 expression and semen parameters.
Introduction
Chemokines (chemotactic cytokines) are small heparin-binding proteins implicated in a wide range of physiological activities, as well as in diseases with prominent inflammatory components. They are classified in four subfamilies, according to a systematic nomenclature based on the relative position of their cysteine residues: CC, CXC, C and CX 3 C chemokines (Murphy et al., 2000; Gerard and Rollins, 2001; Moser and Loetscher, 2001; Bacon et al., 2002) . The largest family consists of CC chemokines (b-chemokines), so named because the first two of the four cysteine residues in these molecules are contiguous. Chemokines affect cell functions by activating surface receptors that are seven-transmembrane -domain G-protein -coupled receptors. The binding of the chemokine to their receptors activates signalling cascades that culminate in the rearrangement, change of shape and cell movement of actin. The CC-chemokine receptor 5 (CCR5) is one of the major receptors of the CC chemokine family (Berger et al., 1999) . In response to b-chemokine ligands, such as RANTES (Regulated on Activation Normal T Expressed and Secreted chemokine), CCR5 is involved in the chemotactic attraction of leukocytes toward sites of chronic inflammation (Schall et al., 1990; Alam et al., 1993; Charo and Ransohoff, 2006) . The CCR5 also plays a central role in modulating cellular susceptibility to HIV-1, as this receptor binds the envelope glycoprotein-120 (gp120) of HIV-1 and facilitates virus entry into CD4-positive target cells (Samson et al., 1996; Berger et al., 1999) . After initial findings that the CC chemokines RANTES, MIP-1a and MIP-1b can inhibit HIV infection in vitro (Cocchi et al., 1995) , the essential involvement of CCR5 in HIV infection has been finally confirmed by the observation that individuals homozygous for a 32-basepair deletion in the CCR5 gene (D32/D32), which disrupts membrane expression of CCR5, are very resistant to HIV infection (Liu et al., 1996; Samson et al., 1996) . Drugs that target this chemokine receptor for HIV disease are currently available (Caldwell and Evans, 2008; Dolin, 2008; Long et al., 2009) .
Interesting evidence has been reported that, besides its role in chronic inflammation, immune responses and HIV-1 infection, the CCR5/RANTES system could be involved in human reproductive events both in physiological and pathological conditions. It has been demonstrated that human spermatozoa contain mRNA coding for CCR5 (Isobe et al., 2002; Januchowski et al., 2004) and express CCR5 protein (Muciaccia et al., 2005a, b) . The chemokine RANTES has been found in seminal plasma (Naz and Leslie, 2000; Penna et al., 2007; Politch et al., 2007) , uterine (Hornung et al., 1997) , peritoneal (Khorram et al., 1993; Hornung et al., 2001) and follicular fluid (Karstrom-Encrantz et al., 1998; Machelon et al., 2000; Xu et al., 2006) , where its levels increase in diseases related to subfertility, such as endometriosis (Khorram et al., 1993; Hornung et al., 2001; Xu et al., 2006) and male genital tract infections (Penna et al., 2007) . The demonstration of an in vitro dose-dependent chemotactic effect of RANTES on human spermatozoa suggested that this chemokine could be one of the physiological chemoattractants of human spermatozoa in follicular fluid (Isobe et al., 2002) . More recently we demonstrated that abnormally high levels of RANTES, comparable to those reported in inflammatory diseases, exert a negative interference on sperm functions involved in the interaction with oocyte (Barbonetti et al., 2008a) .
The role of the CCR5/RANTES system in human reproductive events not only may be affected by chemokine concentrations in male and female genital tract fluids, but it could also be dependent on CCR5 sperm expression. The complex architecture of the mammalian sperm membrane changes throughout development from spermiogenesis to fertilization and major membrane modifications and surface antigens relocalizations have been observed during capacitation (de Lamirande et al., 1997) . Furthermore, although intracellular CCR5 localizations have not yet been reported in spermatozoa, it is known that cell surface expression levels of chemokine receptors in lymphocytes may vary according to the rates of ligand-dependent and constitutive receptor endocytosis and recycling (Signoret et al., 2000; Oppermann, 2004) .
Considerable inter-subject variability in percentage of CCR5-positive freshly ejaculated spermatozoa of healthy normozoospermic donors has been reported, suggesting that, besides functional membrane reorganization processes, the sperm expression of CCR5 protein could be finely regulated by CCR5 gene transcriptional events during spermatogenesis (Muciaccia et al., 2005a, b) . Accordingly, a decrease of CCR5 transcript content in spermatozoa of infertile males has been recently reported as a possible result of defective spermatogenesis and its use as a non-invasive marker of testis-specific subfertility has been hypothesized (Jedrzejczak et al., 2006) . This study aimed to investigate (i) whether the percentage of CCR5-positive spermatozoa may vary under conditions associated with changes in the membrane architecture, such as capacitation and fixation/permeabilization procedures; (ii) whether there is any relationship between individual variability in the sperm CCR5 expression and semen parameters.
Materials and Methods
The study was approved by the Ethic Committee of the Azienda Sanitaria Locale No. 4 of L'Aquila and all subjects signed an informed consent statement.
Subjects, semen analysis and sperm processing
All semen samples were produced by masturbation in a private collection room, close to the Andrology laboratory, into sterile containers. A sexual abstinence of 2 -7 days had been recommended to all subjects. According to World Health Organization criteria for semen analysis (World Health Organization, 1999) , normal sperm parameters were defined as ejaculate volume !2 ml, sperm concentration !20 Â 10 6 /ml, total sperm count (sperm concentration Â volume) !40 Â 10 6 , forward motility (grades a þ b) !50% and normal sperm morphology !15%, according to strict criteria.
The percentage of CCR5-positive spermatozoa under conditions associated with changes in the membrane architecture, such as capacitation and fixation/permeabilization, was evaluated in ejaculated spermatozoa from 10 healthy normozoospermic donors (age: 36 + 6.5 years). Motile sperm suspensions were obtained by swim-up procedure. Briefly, spermatozoa were washed twice (700 g, for 7 min) in Biggers, Whitten and Wittingham (BWW) medium containing 0.1% human serum albumin (HSA; fraction V, no. 1653 Sigma Chemical Co., St Louis, MO, USA). After the second centrifugation, supernatants were removed by aspiration, leaving 0.5 ml on the pellet, and, after an incubation at 378C for 30 min, supernatants (0.5 ml), containing highly concentrated motile sperm (10 Â 10 6 /ml), were carefully aspirated. Capacitated suspensions were obtained by incubation of motile spermatozoa in BWW with the addition of 1% HSA at 378C in an atmosphere of 5% CO 2 /95% air for 5 h, as previously described (Barbonetti et al., 2008a, b) .
In the second part of the study, the relationship between individual variability in sperm CCR5 expression and semen parameters was evaluated in ejaculates produced by 102 men (age: 38 + 7.6 years) who had a semen analysis as a part of the initial investigations for infertile marriages. Patients under pharmacological treatment or with systemic diseases, patients with antisperm-antibodies checked by the SperMAR test (World Health Organization, 1999) and those with more than 1 Â 10 6 /ml round cells in their ejaculate were excluded from the study.
Flow cytometric analysis
Surface expression of CCR5 was analysed in uncapacitated and 5 h-capacitated unfixed sperm samples of 10 normozoospermic healthy donors. In a set of experiments the flow cytometric analysis was also performed before and after a freeze-thawing procedure. Briefly, an aliquot from each sample was placed into sterile polypropylene cryovials (Cryo BioSystem, France) and diluted 1:1 with cryoprotective medium (Test Yolk Buffer with 12% glycerol [v/v] ; Irvine Scientific, Santa Ana, California). Cryoprotective medium was added in a drop-wise fashion over 5 min with constant, gentle agitation. Samples were placed above the liquid nitrogen level for 12 min and then immersed in liquid nitrogen.
To identify the intracellular receptor, inaccessible to antibodies in intact cells, freshly ejaculated spermatozoa were also stained after fixation in ice-cold 1% formaldehyde in phosphate-buffered saline (PBS), for 30 min at 48C, and after permeabilization with 0.1% (v/v) Triton X-100 in PBS, plus 0.1% HSA for 30 min at room temperature (RT).
In the second part of the study, after semen analysis, ejaculates from 102 men with infertile marriages were frozen, as described above and stored in liquid nitrogen (International Cryogenics, Inc., IC 35RX, high capacity refrigerator, Indianapolis, IN, USA) until flow cytometric analysis.
Flow cytometric analysis was performed as previously described with minor modifications (Muciaccia et al., 2005a, b) . Briefly, sperm suspensions (5 Â 10 5 spermatozoa/tube) were incubated for 30 min on ice with 0.5 mg of anti-CCR5 monoclonal antibody (mAb) (IgG2b clone 45 549.111 by R&D Systems) and, in control tubes, with 0.5 mg of corresponding IgG isotype mouse antibody (clone MOPC-141 by Sigma Aldrich). After two washes in PBS solution with 1% HSA, spermatozoa were incubated with a goat anti-mouse phycoerithryn-conjugated polyclonal antibody (BD Bioscience Pharmigen), washed again as above and subsequently analysed by flow cytometry (FACScan flow cytometer, Becton Dickinson Immunocytometry System, San Jose, CA). Data from 10 000 events/sample were collected and analysed using Cell Quest software (Becton Dickinson Immunocytometry System, San Jose, CA). Immunoreactivity for anti-CCR5 mAb was also evaluated with fluorescent microscopy. Briefly, sperm suspensions were incubated with a 1:100 diluted mouse anti-CCR5 mAb or with MOPC-141 at the same concentration as control for 1 h at RT. After two centrifugations (1000 g, 4 min), specific labelling was detected by a goat anti-mouse phycoerithryn-conjugated polyclonal antibody. After repeated washing, spermatozoa were smeared, mounted in PBS -glycerol and observed under a fluorescence microscope (Leica DMLB, Wetzlar, Germany). At least 200 spermatozoa were analysed in each smear.
Statistical analysis
Statistical analysis was performed using the SAS statistical software (version 9.1, 2003; SAS Institute, Inc., Cary, NC). The Spearman's rank (r) correlation coefficient was used to evaluate the relationship between sperm CCR5 expression and semen parameters. Multiple linear regression analysis was performed to establish which variable (among the routine semen parameters) could explain a significant variation in individual sperm CCR5 expression. A stepwise procedure was used to select variables to be included into the model. A variable was entered into the model for P-value a 0.05. Differences in semen parameters among quartiles of increasing sperm CCR5 expression (%) were evaluated with the Kruskal-Wallis test. Post hoc comparisons were performed with the Wilcoxon two-sample test and P , 0.05 was considered significant.
Results

CCR5 in human spermatozoa: effect of capacitation and membrane permeabilization
In ejaculates from 10 normozoospermic healthy donors, the percentage of CCR5-positive unfixed fresh spermatozoa varied from 10.3 to 60.2% (median 49%) and its significant decreases, varying from 224% to 288%, were always observed after 5 h capacitation (P , 0.05) (Fig. 1A,B) . After sperm fixation and membrane permeabilization, the percentage of positive spermatozoa was significantly higher than in unfixed samples with a median of 95.8% (range 91.3 -98.0%; P , 0.05), whereas it was not significantly affected by freeze-thawing procedure (median 45%, range 12.5 -65%) (Fig. 1A) .
As shown in Fig. 2 , immunoreactivity for anti-CCR5 mAb was restricted to the anterior region of the head of unfixed spermatozoa. This localization pattern remained unchanged after 5 h capacitation and fixation/permeabilization, although the proportion of CCR5-positive cells appeared to be always decreased after capacitation and increased after fixation/permeabilization (not shown).
Sperm CCR5 expression and semen quality in men with infertile marriages Semen parameters in the study population of 102 men with infertile marriages are reported in Table I .
As the percentage of CCR5-positive spermatozoa was not significantly affected by the freeze-thawing procedure (Fig. 1A) , in this set of experiments flow cytometry was performed in frozen/thawed ejaculates. The percentage of CCR5-positive spermatozoa largely varied from 0.7 to 61.4% and it was significantly higher in patients with normal (median 37, range 11.5 -56.9%) than in those with one or more abnormal semen parameters (median 23.3, range 0.7-61.4%; P ¼ 0.005; Fig. 3) .
A significant positive correlation was found between CCR5 expression and sperm count (r ¼ 0.31; P ¼ 0.0013), total sperm number (r ¼ 0.30; P ¼ 0.0017) and percentage of forward motility (r ¼ 0.37; P ¼ 0.001), whereas a negative correlation was observed with the percentage of immotile spermatozoa (r ¼ 20.34; P ¼ 0.0004) (Fig. 4) . There was no correlation between CCR5 expression and percentage of spermatozoa with typical morphology (r ¼ 0.2; P .
0.05).
The interquartile analysis showed significant differences between the first and fourth quartiles of CCR5 expression for all semen parameters, with the exception of sperm morphology (Fig. 5) .
To identify which independent variable (among the routine semen parameters) explained a significant variation in CCR5 sperm expression, we used a stepwise multiple linear regression model. This analysis demonstrated that only the forward motility satisfied the criteria to be included into the model (P ¼ 0.0067), explaining, however, only 7.8% of the variability in CCR5 expression.
Finally, although subjects with more than 1 Â 10 6 /ml round cells in their ejaculate were excluded from the study, to exclude any possible relationship between seminal leukocytes and sperm CCR5 expression, ejaculates were divided into quartiles, according to the number of seminal leukocytes. The percentage of CCR5-positive spermatozoa did not differ significantly between the lowest ( 0.1 Â 10 6 leukocytes/ml) and the highest (0.6 -0.8 Â 10 6 leukocytes/ml) quartile: median values were 35% (range: 6.8 -59.6%) and 33% (range: 11.5 -43.4%), respectively (P . 0.05).
Discussion
The present study demonstrates that CCR5 protein is present on the surface of freshly ejaculated unfixed spermatozoa. In flow cytometric analysis, in different samples from normozoospermic healthy donors, the percentage of CCR5-positive spermatozoa widely varied from 10 to 60% and immunocytochemistry experiments located the receptor on the periacrosomal region of the sperm head. Our data are in agreement with the recent demonstration of CCR5 transcripts and protein in human spermatozoa (Isobe et al., 2002; Januchowski et al., 2004; Muciaccia et al., 2005a, b) , shedding light on how these cells could act as virion carriers during the sexual transmission of HIV-1 infection (Dussaix et al., 1993) . We suggest that previous failure (Kim et al., 1999) to demonstrate significant CCR5 levels on human spermatozoa by flow cytometry, using a fluorescein isothiocyanate (FITC)-labelled monoclonal antibody, could have been due to technical problems. According to Muciaccia et al. (2005b) , in our hands, the use of phycoerithryn fluorochrome, as opposed to FITC, increased detection sensitivity, and clone 45 549.111 antibody is the most suitable anti-human CCR5 antibody, with regard to both sensitivity and specificity. Indeed, it has been reported that using SDS-PAGE/western blot assay on total proteins extracted from spermatozoa positive for CCR5 at flow cytometry, the clone 45 549.111 does not cross-react with CCR1, CCR2 or CCR3 and recognizes a specific immunoreactive band at the expected molecular weight of human CCR5 and similar to that observed in peripheral blood mononuclear cells, used as positive controls (Muciaccia et al., 2005b) . Interestingly, the percentage of CCR5-positive spermatozoa appeared to be affected by different conditions associated with changes in membrane architecture, without apparent cellular relocalization of the receptor. With respect to unfixed fresh spermatozoa, the percentage of CCR5-positive cells was significantly decreased after 5 h capacitation, whereas it increased up to more than 90% after fixation and Triton X-induced-membrane permeabilization. As fixation and permeabilization procedures allow antibody access inside the cell, the increased detection of CCR5 in fixed/permeabilized spermatozoa would suggest the existence of a large intracellular pool of the receptor.
The meaning of the intracellular localization of CCR5 and the reasons for its capacitation-related lower surface expression in human spermatozoa are currently unknown. However, in several cell types it has been demonstrated that membrane expression levels of chemokine receptors may vary according to complex endocytosis and recycling processes (Signoret et al., 2000; Oppermann, 2004) . Although chemokine receptors may undergo intracellular sequestration upon interacting with its natural ligands (Zaitseva et al., 1997; Forster et al., 1998; Tarasova et al., 1998) , it has been reported that these receptors also exhibit a constitutive intracellular localization, suggesting that their internalization may occur as both ligand-dependent and ligand-independent processes (Signoret et al., 1997; Signoret et al., 2000; Maldonado-Estrada et al., 2003; Oppermann, 2004) . Notably, spontaneous receptor trafficking and endocytosis could account for very low or no surface cellular expression but a high intracytoplasmic pool (Signoret et al., 1997) . Furthermore, it should be underlined that various cell types may release CCR5-containing membrane microparticles that, taken up by other CCR5-negative cells, would lead to a cellular transfer of the chemokine receptor . On the whole, sperm capacitation, considered to involve significant changes in the membrane architecture (Holt, 1995; de Lamirande et al., 1997) , could facilitate these events, potentially contributing to more intensive trafficking processes of CCR5. This is an attractive speculation, needing further investigations. In fact, as spermatozoa are both transcriptionally and translationally inactive cells, a CCR5 recycling could provide a subtle and dynamic control for its membrane expression. Because the natural ligand of CCR5, RANTES, is produced within the female genital tract environment, CCR5 membrane trafficking and intracellular reservoir of this receptor could tightly regulate the sperm responsiveness to the b-chemokine. In this view, as hypothesized for other chemokine receptors in different biological models (Zhang et al., 2004) , a decreased surface expression of CCR5 could hinder sperm hyperstimulations by excess of its extracellular natural ligands. Intriguingly, we recently demonstrated that high levels of RANTES, comparable with those reported in inflammatory diseases of the female and male genital tract, may exert a negative interference on sperm functions involved in the acquisition of fertilizing ability (Barbonetti et al., 2008a) .
The wide inter-subject variability in percentage of CCR5-positive freshly ejaculated spermatozoa of normozoospermic healthy donors, could suggest that, besides possible functional membrane reorganization processes, the surface sperm expression of CCR5 protein could be dependent on CCR5 gene transcriptional events that occurred during spermatogenesis (Muciaccia et al., 2005a, b) . Accordingly, a low CCR5 transcript content in spermatozoa of infertile males has been recently reported as a possible result of defective spermatogenesis (Jedrzejczak et al., 2006) . However, whether or to what extent, a decreased CCR5 transcript content in spermatozoa of infertile males may also cause low content of sperm CCR5 protein, in each specific category of male subfertility, is still unknown. In order to investigate whether there was any relationship between individual variability in the sperm CCR5 expression and semen parameters, in the second part of the study, we analysed ejaculates from 102 men who had a semen analysis for infertile marriages. Interestingly, the average rate of sperm CCR5 expression was higher in normozoospermic subjects than in those with one or more abnormal semen parameters and a lower expression of CCR5 in asthenozoospermia was suggested by correlation and interquartile analyses. As it is unlikely that low sperm motility and decreased CCR5 expression (at head level) are linked by a causative relationship, we hypothesized that a decreased sperm CCR5 expression could be dependent on defective spermatogenesis and/or functional membrane modifications produced by an adverse epididymal environment, also leading to oligozoospermia and/or asthenozoospermia. On the other hand, at the stepwise multiple linear regression, forward motility resulted to explain only 8% of the interindividual variability in CCR5 expression, suggesting possible genetic contributions to the variability. Numerous CCR5 gene polymorphisms and mutations, variously inhibiting the expression of the chemokine receptor on the plasma membrane of different cellular models, have been reported (Quillent et al., 1998; McDermott et al., 1998; Blanpain et al., 2000; Tamasauskas et al., 2001) . Among these a 32 nucleotide deletion (D32) in the CCR5 gene region is known to be responsible for the lack of CCR5 receptor expression on the cell membrane (Liu et al., 1996) . Individuals bearing the D32 2/2 defective CCR5 gene are resistant to HIV infection in spite of multiple sexual viral exposures (Liu et al., 1996; Samson et al., 1996) , whereas heterozygous individuals for this mutation exhibit a slower disease progression and a lower blood viral load (Huang et al., 1996) . Interestingly, the presence of D32 þ/2 mutation has been recently reported in two subjects expressing CCR5 in half of their ejaculated spermatozoa (Muciaccia et al., 2005b) .
In conclusion, data from the present study showed that the percentage of CCR5-positive spermatozoa may vary under conditions associated with changes in the membrane architecture, such as capacitation and fixation/permeabilization procedures, and spermatozoa appeared to exhibit a large intracellular pool of CCR5. A lower expression of CCR5 in asthenozoospermia could be suggested, although forward motility only partially contributed to the inter-individual variability in the CCR5 expression. A genetic basis can be hypothesized to explain this variability.
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